News

December 18, 2018December 18, 2018

Verona Pharma’s Phase 2 Trial Evaluating RPL554 for COPD Set to Begin

News

A Phase 2 clinical trial is enrolling participants to evaluate the safety and efficacy of Verona Pharma’s dry powder inhaler RPL554 as a potential maintenance treatment for people with moderate to ... Read more

December 11, 2018December 11, 2018

Obesity Strongly Linked to COPD in Individuals Who Never Smoked, Study Reports

News

Chronic obstructive pulmonary disease (COPD) is much more common in obese individuals ages 50 and older who have never smoked, according to a study that also shows that the ... Read more

December 4, 2018December 4, 2018

Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows

News

Very few patients with chronic obstructive pulmonary disease (COPD) start pulmonary rehabilitation after being hospitalized, despite its proven benefits and clinical guidelines recommending it shortly after discharge, a study ... Read more

November 27, 2018November 27, 2018

Mucus Protects Lungs by Forming Layers, Preventing Worsening of Lung Diseases, Studies Reveal

News

Two new studies highlight the important role of mucus in cleaning and protecting the lungs, and how its accumulation and impaired clearance can contribute to the worsening of lung diseases ... Read more

November 20, 2018November 20, 2018

Royal Philips Launching Motivational and Awareness Campaign to Mark World COPD Day

News

Health technology company Royal Philips is launching a global initiative on World COPD Day Wednesday in hopes of raising awareness of chronic obstructive pulmonary disease (COPD) and encouraging patients to remain active ... Read more

November 13, 2018November 13, 2018

FDA Approves Yupelri as New Treatment for Adults with COPD

News

Theravance Biopharma and Mylan announced that the U.S. Food and Drug Administration (FDA) approved their New Drug Application (NDA) for revefenacin (TD-4208) as a maintenance treatment for chronic obstructive pulmonary ... Read more

November 6, 2018November 6, 2018

COPD Foundation Launches App to Help Providers, Patients

News

The COPD Foundation has launched an app called the COPD Pocket Consultant Guide (PCG), designed to help healthcare providers in the treatment and management of patients with chronic obstructive pulmonary ... Read more

October 30, 2018October 30, 2018

COPD Patients Begin to Receive Synairgen’s Therapy SNG001 for Flu, Colds in Phase 2 Trial

News

Treatment administration has started in the second part of a Phase 2 trial evaluating the safety and efficacy of Synairgen‘s inhaled therapeutic candidate SNG001 in patients with chronic obstructive pulmonary ... Read more

October 26, 2018October 26, 2018

Analysis of Long-term Oxygen Use in Some COPD Patients Makes Researchers Question Its Benefits

News

Long-term oxygen therapy may not benefit patients with mild to moderate chronic obstructive pulmonary disease (COPD) with low levels of oxygen in the blood (hypoxemia), a meta-analysis has shown. ... Read more

October 23, 2018October 23, 2018

Long-term Benzodiazepine Use May Increase COPD Patients’ Suicide Risk, Study Suggests

News

Patients with chronic obstructive pulmonary disease (COPD) on long-term treatment with benzodiazepines are at a higher risk for suicide, a study suggests. The study, “Risks of Benzodiazepines in Chronic ... Read more

Pin It on Pinterest